Publication | Open Access
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects
86
Citations
38
References
2015
Year
Merck & Co. Inc., Kenilworth, New Jersey, USA. Additional support for instrumentation was obtained from the National Center for Advancing Translational Sciences (UL1TR000003 and UL1TR000040).
| Year | Citations | |
|---|---|---|
Page 1
Page 1